| 标题 |
Certolizumab pegol plus MTX administered every 4 weeks is effective in patients with RA who are partial responders to MTX |
| 网址 | |
| DOI |
10.1093/rheumatology/ker519
doi
|
| 其它 |
期刊:Rheumatology 作者:E. Choy; F. McKenna; J. Vencovsky; R. Valente; N. Goel; et al 出版日期:2012-02-16 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)